Human Phenotype Ontology 
Grandparent Node:
expand
Morphological central nervous system abnormality (HP:0002011)help
Parent Node:
expand
Atrophy/Degeneration affecting the central nervous system (HP:0007367)help
..Starting node
..expand
Neurodegeneration (HP:0002180)help
Term ID: 2180
Name: Neurodegeneration
Synonym: Neuro-degenerative disease; Neurodegenerative disease; Ongoing loss of nerve cells; Progressive neurodegenerative disorder
Definition: Progressive loss of neural cells and tissue.
Comments:
Reference: HP:0002180
Genes and Diseases:
 
       Child Nodes:
........expandDegeneration of the striatum (HP:0040140) help

 Sister Nodes: 
..expandAtrophy/Degeneration affecting the brainstem (HP:0007366) help
..expandAtrophy/Degeneration involving the corticospinal tracts (HP:0007372) help
..expandAtrophy/Degeneration involving the spinal cord (HP:0007344) help
..expandBrain atrophy (HP:0012444) help
..expandCentral nervous system degeneration (HP:0007009) help
..expandIncreased cerebral lipofuscin (HP:0011813) help
..expandMotor neuron atrophy (HP:0007373) help
..expandNeuronal loss in central nervous system (HP:0002529) help
..expandSenile plaques (HP:0100256) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002180HP:0002180Neurodegeneration0AARS2 CL E G H5750521022OMIM:615889Leukoencephalopathy, progressive, with ovarian failure.143
HP:0002180HP:0002180Neurodegeneration0ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy.135
HP:0002180HP:0002180Neurodegeneration0ADAR CL E G H103225ORPHA:51Aicardi-Goutières syndrome116
HP:0002180HP:0002180Neurodegeneration0ANG CL E G H283483ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent32
HP:0002180HP:0002180Neurodegeneration0ANXA11 CL E G H311535ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0ATXN2 CL E G H631110555ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent11
HP:0002180HP:0002180Neurodegeneration0ATXN3 CL E G H42877106ORPHA:276238Machado-Joseph disease type 114
HP:0002180HP:0002180Neurodegeneration0ATXN3 CL E G H42877106ORPHA:276241Machado-Joseph disease type 214
HP:0002180HP:0002180Neurodegeneration0ATXN3 CL E G H42877106ORPHA:276244Machado-Joseph disease type 314
HP:0002180HP:0002180Neurodegeneration0C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4.114
HP:0002180HP:0002180Neurodegeneration0C9ORF72 CL E G H20322828337ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent56
HP:0002180HP:0002180Neurodegeneration0CCNF CL E G H8991591ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0CFAP410 CL E G H7551260ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0CHCHD10 CL E G H40091615559ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent11
HP:0002180HP:0002180Neurodegeneration0CHMP2B CL E G H2597824537ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent42
HP:0002180HP:0002180Neurodegeneration0COASY CL E G H8034729932OMIM:615643Neurodegeneration with brain iron accumulation 6.16
HP:0002180HP:0002180Neurodegeneration0COQ2 CL E G H2723525223OMIM:146500Multiple system atrophy 1, susceptibility to.54
HP:0002180HP:0002180Neurodegeneration0CSF1R CL E G H14362433OMIM:618476Brain abnormalities, neurodegeneration, and dysosteosclerosis.149
HP:0002180HP:0002180Neurodegeneration0DAO CL E G H16102671ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0DCTN1 CL E G H16392711ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent86
HP:0002180HP:0002180Neurodegeneration0DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiencyHP:0040282 - Frequent82
HP:0002180HP:0002180Neurodegeneration0EPHA4 CL E G H20433388ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent4
HP:0002180HP:0002180Neurodegeneration0ERBB4 CL E G H20663432ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent15
HP:0002180HP:0002180Neurodegeneration0ERCC6 CL E G H20743438OMIM:214150Cerebrooculofacioskeletal syndrome 1199
HP:0002180HP:0002180Neurodegeneration0FA2H CL E G H7915221197OMIM:612319Spastic paraplegia 35, autosomal recessive.76
HP:0002180HP:0002180Neurodegeneration0FIG4 CL E G H989616873ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent111
HP:0002180HP:0002180Neurodegeneration0FOLR1 CL E G H23483791OMIM:613068Neurodegeneration due to cerebral folate transport deficiency.47
HP:0002180HP:0002180Neurodegeneration0FTL CL E G H25123999OMIM:606159Neurodegeneration with brain iron accumulation 3.33
HP:0002180HP:0002180Neurodegeneration0FUS CL E G H25214010ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent105
HP:0002180HP:0002180Neurodegeneration0GALC CL E G H25814115OMIM:245200Krabbe disease.160
HP:0002180HP:0002180Neurodegeneration0GLE1 CL E G H27334315ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent45
HP:0002180HP:0002180Neurodegeneration0GLT8D1 CL E G H5583024870ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0GM2A CL E G H27604367ORPHA:309246GM2 gangliosidosis, AB variantHP:0040281 - Very frequent69
HP:0002180HP:0002180Neurodegeneration0GM2A CL E G H27604367OMIM:272750Gm2-Gangliosidosis, ab variant.69
HP:0002180HP:0002180Neurodegeneration0GUSB CL E G H29904696OMIM:253220Mucopolysaccharidosis, type VII.54
HP:0002180HP:0002180Neurodegeneration0HNRNPA1 CL E G H31785031ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent31
HP:0002180HP:0002180Neurodegeneration0HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile typeHP:0040282 - Frequent19
HP:0002180HP:0002180Neurodegeneration0HTT CL E G H30644851ORPHA:399Huntington disease12
HP:0002180HP:0002180Neurodegeneration0IDS CL E G H34235389OMIM:309900Mucopolysaccharidosis, type II.86
HP:0002180HP:0002180Neurodegeneration0IDUA CL E G H34255391OMIM:607014Hurler syndrome.115
HP:0002180HP:0002180Neurodegeneration0IFIH1 CL E G H6413518873ORPHA:51Aicardi-Goutières syndrome28
HP:0002180HP:0002180Neurodegeneration0LSM11 CL E G H13435330860ORPHA:51Aicardi-Goutières syndrome
HP:0002180HP:0002180Neurodegeneration0LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0002180HP:0002180Neurodegeneration0MAPT CL E G H41376893OMIM:601104Supranuclear palsy, progressive, 1140
HP:0002180HP:0002180Neurodegeneration0MATR3 CL E G H97826912ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent80
HP:0002180HP:0002180Neurodegeneration0MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7.120
HP:0002180HP:0002180Neurodegeneration0NARS2 CL E G H7973126274OMIM:616239Combined oxidative phosphorylation deficiency 24.34
HP:0002180HP:0002180Neurodegeneration0NAXD CL E G H5573925576OMIM:618321Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2.
HP:0002180HP:0002180Neurodegeneration0NBN CL E G H46837652OMIM:251260Nijmegen breakage syndrome.706
HP:0002180HP:0002180Neurodegeneration0NEFH CL E G H47447737ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent24
HP:0002180HP:0002180Neurodegeneration0NEK1 CL E G H47507744ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent101
HP:0002180HP:0002180Neurodegeneration0OPTN CL E G H1013317142ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent62
HP:0002180HP:0002180Neurodegeneration0PANK2 CL E G H8002515894OMIM:234200Neurodegeneration with brain iron accumulation 1.55
HP:0002180HP:0002180Neurodegeneration0PCNA CL E G H51118729OMIM:615919Ataxia-Telangiectasia-Like disorder 2.1
HP:0002180HP:0002180Neurodegeneration0PCNA CL E G H51118729ORPHA:438134PCNA-related progressive neurodegenerative photosensitivity syndromeHP:0040281 - Very frequent1
HP:0002180HP:0002180Neurodegeneration0PDE8B CL E G H86228794OMIM:609161Striatal degeneration, autosomal dominant75
HP:0002180HP:0002180Neurodegeneration0PFN1 CL E G H52168881ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent6
HP:0002180HP:0002180Neurodegeneration0PLA2G6 CL E G H83989039OMIM:256600Neurodegeneration with brain iron accumulation 2A.133
HP:0002180HP:0002180Neurodegeneration0PLA2G6 CL E G H83989039OMIM:610217Neurodegeneration with brain iron accumulation 2B.133
HP:0002180HP:0002180Neurodegeneration0PON1 CL E G H54449204ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent4
HP:0002180HP:0002180Neurodegeneration0PON2 CL E G H54459205ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent2
HP:0002180HP:0002180Neurodegeneration0PON3 CL E G H54469206ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent1
HP:0002180HP:0002180Neurodegeneration0PPARGC1A CL E G H108919237ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent1
HP:0002180HP:0002180Neurodegeneration0PRNP CL E G H56219449OMIM:245300KURU, SUSCEPTIBILITY TO69
HP:0002180HP:0002180Neurodegeneration0PRPH CL E G H56309461ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent25
HP:0002180HP:0002180Neurodegeneration0RNASEH2A CL E G H1053518518ORPHA:51Aicardi-Goutières syndrome33
HP:0002180HP:0002180Neurodegeneration0RNASEH2B CL E G H7962125671ORPHA:51Aicardi-Goutières syndrome34
HP:0002180HP:0002180Neurodegeneration0RNASEH2C CL E G H8415324116ORPHA:51Aicardi-Goutières syndrome60
HP:0002180HP:0002180Neurodegeneration0RNU7-1 CL E G H10014774434033ORPHA:51Aicardi-Goutières syndrome
HP:0002180HP:0002180Neurodegeneration0SAMHD1 CL E G H2593915925ORPHA:51Aicardi-Goutières syndrome55
HP:0002180HP:0002180Neurodegeneration0SLC2A3 CL E G H651511007ORPHA:399Huntington disease1
HP:0002180HP:0002180Neurodegeneration0SOD1 CL E G H664711179ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent53
HP:0002180HP:0002180Neurodegeneration0SPTBN1 CL E G H671111275OMIM:619475DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
HP:0002180HP:0002180Neurodegeneration0SQSTM1 CL E G H887811280ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent62
HP:0002180HP:0002180Neurodegeneration0TAF15 CL E G H814811547ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent
HP:0002180HP:0002180Neurodegeneration0TANGO2 CL E G H12898925439OMIM:616878Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration.12
HP:0002180HP:0002180Neurodegeneration0TARDBP CL E G H2343511571ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent65
HP:0002180HP:0002180Neurodegeneration0TBK1 CL E G H2911011584ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent20
HP:0002180HP:0002180Neurodegeneration0TREM2 CL E G H5420917761ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent31
HP:0002180HP:0002180Neurodegeneration0TREX1 CL E G H1127712269ORPHA:51Aicardi-Goutières syndrome56
HP:0002180HP:0002180Neurodegeneration0TTC19 CL E G H5490226006OMIM:615157Mitochondrial complex III deficiency, nuclear type 2.88
HP:0002180HP:0002180Neurodegeneration0TXN2 CL E G H2582817772ORPHA:478029Combined oxidative phosphorylation defect type 29HP:0040281 - Very frequent1
HP:0002180HP:0002180Neurodegeneration0UBQLN2 CL E G H2997812509ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent20
HP:0002180HP:0002180Neurodegeneration0UBTF CL E G H734312511OMIM:617672Neurodegeneration, childhood-onset, with brain atrophy.1
HP:0002180HP:0002180Neurodegeneration0UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive.21
HP:0002180HP:0002180Neurodegeneration0UNC13A CL E G H2302523150ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent1
HP:0002180HP:0002180Neurodegeneration0VAPB CL E G H921712649ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent116
HP:0002180HP:0002180Neurodegeneration0VCP CL E G H741512666ORPHA:803Amyotrophic lateral sclerosisHP:0040281 - Very frequent63
HP:0002180HP:0002180Neurodegeneration0WDR45 CL E G H1115228912OMIM:300894Neurodegeneration with brain iron accumulation 5.51
HP:0002180HP:0002180Neurodegeneration0ZBTB20 CL E G H2613713503OMIM:259050Primrose syndrome.17
HP:0002180HP:0040140Degeneration of the striatum1ADAR CL E G H103225ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare116
HP:0002180HP:0040140Degeneration of the striatum1ATXN3 CL E G H42877106ORPHA:276238Machado-Joseph disease type 1HP:0040282 - Frequent14
HP:0002180HP:0040140Degeneration of the striatum1ATXN3 CL E G H42877106ORPHA:276241Machado-Joseph disease type 2HP:0040282 - Frequent14
HP:0002180HP:0040140Degeneration of the striatum1ATXN3 CL E G H42877106ORPHA:276244Machado-Joseph disease type 3HP:0040282 - Frequent14
HP:0002180HP:0040140Degeneration of the striatum1HTT CL E G H30644851ORPHA:399Huntington diseaseHP:0040283 - Occasional12
HP:0002180HP:0040140Degeneration of the striatum1IFIH1 CL E G H6413518873ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare28
HP:0002180HP:0040140Degeneration of the striatum1LSM11 CL E G H13435330860ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare
HP:0002180HP:0002528Granulovacuolar degeneration1MAPT CL E G H41376893OMIM:601104Supranuclear palsy, progressive, 1.140
HP:0002180HP:0040140Degeneration of the striatum1PDE8B CL E G H86228794OMIM:609161Striatal degeneration, autosomal dominant.75
HP:0002180HP:0040140Degeneration of the striatum1RNASEH2A CL E G H1053518518ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare33
HP:0002180HP:0040140Degeneration of the striatum1RNASEH2B CL E G H7962125671ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare34
HP:0002180HP:0040140Degeneration of the striatum1RNASEH2C CL E G H8415324116ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare60
HP:0002180HP:0040140Degeneration of the striatum1RNU7-1 CL E G H10014774434033ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare
HP:0002180HP:0040140Degeneration of the striatum1SAMHD1 CL E G H2593915925ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare55
HP:0002180HP:0040140Degeneration of the striatum1SLC2A3 CL E G H651511007ORPHA:399Huntington diseaseHP:0040283 - Occasional1
HP:0002180HP:0040140Degeneration of the striatum1TREX1 CL E G H1127712269ORPHA:51Aicardi-Goutières syndromeHP:0040284 - Very rare56


Genes (85) :AARS2 ABCD1 ADAR ANG ANXA11 ATXN2 ATXN3 C19ORF12 C9ORF72 CCNF CFAP410 CHCHD10 CHMP2B COASY COQ2 CSF1R DAO DCTN1 DLAT EPHA4 ERBB4 ERCC6 FA2H FIG4 FOLR1 FTL FUS GALC GLE1 GLT8D1 GM2A GUSB HNRNPA1 HSD17B10 HTT IDS IDUA IFIH1 LSM11 LYST MAPT MATR3 MFSD8 NARS2 NAXD NBN NEFH NEK1 OPTN PANK2 PCNA PDE8B PFN1 PLA2G6 PON1 PON2 PON3 PPARGC1A PRNP PRPH RNASEH2A RNASEH2B RNASEH2C RNU7-1 SAMHD1 SLC2A3 SOD1 SPTBN1 SQSTM1 TAF15 TANGO2 TARDBP TBK1 TREM2 TREX1 TTC19 TXN2 UBQLN2 UBTF UCHL1 UNC13A VAPB VCP WDR45 ZBTB20

Diseases (45) :OMIM:615889 OMIM:300100 ORPHA:51 ORPHA:803 ORPHA:276238 ORPHA:276241 ORPHA:276244 OMIM:614298 OMIM:615643 OMIM:146500 OMIM:618476 ORPHA:79244 OMIM:214150 OMIM:612319 OMIM:613068 OMIM:606159 OMIM:245200 ORPHA:309246 OMIM:272750 OMIM:253220 ORPHA:391428 ORPHA:399 OMIM:309900 OMIM:607014 OMIM:214500 OMIM:601104 OMIM:610951 OMIM:616239 OMIM:618321 OMIM:251260 OMIM:234200 OMIM:615919 ORPHA:438134 OMIM:609161 OMIM:256600 OMIM:610217 OMIM:245300 OMIM:619475 OMIM:616878 OMIM:615157 ORPHA:478029 OMIM:617672 OMIM:615491 OMIM:300894 OMIM:259050
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.